276 related articles for article (PubMed ID: 33258019)
1. [Prospective monitoring of a university rheumatology outpatient clinic throughout the first wave of the COVID-19 pandemic : What lessons can be learned?].
Braunisch MC; Bachmann Q; Hammitzsch A; Lorenz G; Geisler F; Schmaderer C; Heemann U; Moog P
Z Rheumatol; 2021 Jun; 80(5):408-417. PubMed ID: 33258019
[TBL] [Abstract][Full Text] [Related]
2. [SARS-CoV-2 & rheumatic disease : Consequences of the SARS-CoV-2 pandemic for patients with inflammatory rheumatic diseases. A comparison of the recommendations for action of rheumatological societies and risk assessment of different antirheumatic treatments].
Leipe J; Hoyer BF; Iking-Konert C; Schulze-Koops H; Specker C; Krüger K
Z Rheumatol; 2020 Sep; 79(7):686-691. PubMed ID: 32845393
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes of Covid-19 in patients with rheumatic diseases and the effects of the pandemic on rheumatology outpatient care: A single-centre experience from Turkey.
Batıbay S; Koçak Ulucaköy R; Özdemir B; Günendi Z; Göğüş FN
Int J Clin Pract; 2021 Sep; 75(9):e14442. PubMed ID: 34105856
[TBL] [Abstract][Full Text] [Related]
4. Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in times of SARS-CoV-2-methodology, key messages and justifying information.
Schulze-Koops H; Krüger K; Hoyer BF; Leipe J; Iking-Konert C; Specker C;
Rheumatology (Oxford); 2021 May; 60(5):2128-2133. PubMed ID: 33502500
[TBL] [Abstract][Full Text] [Related]
5. [Current guidance of the German Society of Rheumatology for the care of patients with rheumatic diseases during the SARS-CoV-2/Covid 19 pandemic].
Schulze-Koops H; Holle J; Moosig F; Specker C; Aries P; Burmester G; Fiehn C; Hoyer B; Krause A; Leipe J; Lorenz HM; Schneider M; Sewerin P; Voormann A; Wager U; Krüger K; Iking-Konert C;
Z Rheumatol; 2020 May; 79(4):385-388. PubMed ID: 32342184
[TBL] [Abstract][Full Text] [Related]
6. [Recommendations of the German Society for Rheumatology for management of patients with inflammatory rheumatic diseases in the context of the SARS-CoV-2/COVID-19 pandemic - Update July 2020].
Schulze-Koops H; Iking-Konert C; Leipe J; Hoyer BF; Holle J; Moosig F; Aries P; Burmester G; Fiehn C; Krause A; Lorenz HM; Schneider M; Sewerin P; Voormann A; Wagner U; Krüger K; Specker C; ;
Z Rheumatol; 2020 Sep; 79(7):679-685. PubMed ID: 32757030
[TBL] [Abstract][Full Text] [Related]
7. [Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in the context of the SARS-CoV‑2/COVID‑19 pandemic, including recommendations for COVID‑19 vaccination].
Specker C; Aries P; Braun J; Burmester G; Fischer-Betz R; Hasseli R; Holle J; Hoyer BF; Iking-Konert C; Krause A; Krüger K; Krusche M; Leipe J; Lorenz HM; Moosig F; Schmale-Grede R; Schneider M; Strangfeld A; Voll R; Voormann A; Wagner U; Schulze-Koops H
Z Rheumatol; 2021 Aug; 80(6):570-587. PubMed ID: 34309739
[No Abstract] [Full Text] [Related]
8. [German registry www.Covid19-Rheuma.de : Status report after 1 year of the pandemic].
Hasseli R; Pfeil A; Hoyer BF; Lorenz HM; Regierer AC; Richter JG; Schmeiser T; Strangfeld A; Voll RE; Krause A; Schulze-Koops H; Müller-Ladner U; Specker C
Z Rheumatol; 2021 Sep; 80(7):641-646. PubMed ID: 34196793
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: A cross-sectional study on 916 patients.
Zen M; Fuzzi E; Astorri D; Saccon F; Padoan R; Ienna L; Cozzi G; Depascale R; Zanatta E; Gasparotto M; Benvenuti F; Bindoli S; Gatto M; Felicetti M; Ortolan A; Campaniello D; Larosa M; Lorenzin M; Ramonda R; Sfriso P; Schiavon F; Iaccarino L; Doria A
J Autoimmun; 2020 Aug; 112():102502. PubMed ID: 32527675
[TBL] [Abstract][Full Text] [Related]
10. Managing patients with rheumatic diseases during the COVID-19 pandemic: The French Society of Rheumatology answers to most frequently asked questions up to May 2020.
Richez C; Flipo RM; Berenbaum F; Cantagrel A; Claudepierre P; Debiais F; Dieudé P; Goupille P; Roux C; Schaeverbeke T; Wendling D; Pham T; Thomas T
Joint Bone Spine; 2020 Oct; 87(5):431-437. PubMed ID: 32473418
[TBL] [Abstract][Full Text] [Related]
11. The impact of the ongoing COVID-19 pandemic on the management of rheumatic disease: a national clinician-based survey.
Kahveci A; Gümüştepe A; Güven N; Ataman Ş
Rheumatol Int; 2022 Apr; 42(4):601-608. PubMed ID: 35165770
[TBL] [Abstract][Full Text] [Related]
12. [Does methotrexate influence the efficacy of vaccination against SARS-CoV-2?].
Krüger K;
Z Rheumatol; 2021 Aug; 80(6):552-554. PubMed ID: 34132881
[TBL] [Abstract][Full Text] [Related]
13. Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in the context of the SARS-CoV-2/COVID-19 pandemic, including recommendations for COVID-19 vaccination.
Specker C; Aries P; Braun J; Burmester G; Fischer-Betz R; Hasseli R; Holle J; Hoyer BF; Iking-Konert C; Krause A; Krüger K; Krusche M; Leipe J; Lorenz HM; Moosig F; Schmale-Grede R; Schneider M; Strangfeld A; Voll R; Voormann A; Wagner U; Schulze-Koops H
Z Rheumatol; 2021 Dec; 80(Suppl 2):33-48. PubMed ID: 34491403
[No Abstract] [Full Text] [Related]
14. The influence of the SARS-CoV-2 lockdown on patients with inflammatory rheumatic diseases on their adherence to immunomodulatory medication: a cross sectional study over 3 months in Germany.
Hasseli R; Müller-Ladner U; Keil F; Broll M; Dormann A; Fräbel C; Hermann W; Heinmüller CJ; Hoyer BF; Löffler F; Özden F; Pfeiffer U; Saech J; Schneidereit T; Schlesinger A; Schwarting A; Specker C; Stapfer G; Steinmüller M; Storck-Müller K; Strunk J; Thiele A; Triantafyllias K; Vagedes D; Wassenberg S; Wilden E; Zeglam S; Schmeiser T
Rheumatology (Oxford); 2021 Oct; 60(SI):SI51-SI58. PubMed ID: 33704418
[TBL] [Abstract][Full Text] [Related]
15. Updated APLAR consensus statements on care for patients with rheumatic diseases during the COVID-19 pandemic.
Tam LS; Tanaka Y; Handa R; Li Z; Lorenzo JP; Louthrenoo W; Hill C; Pile K; Robinson PC; Dans LF; Hsu LY; Lee SM; Cho J; Hasan ATMT; Salim B; Samreen S; Shaharir SS; Wong P; Chau J; Danda D; Haq SA
Int J Rheum Dis; 2021 Jun; 24(6):733-745. PubMed ID: 33945214
[TBL] [Abstract][Full Text] [Related]
16. Look after the COVID-19 pandemic: Mortality rates among patients with rheumatic diseases.
Çimen Güneş E; Çolak S; Şenlik ZB; Tekgöz E; Altunay K; Özdemirkan T; Aytaç BC; Şimşek AÇ; Çınar M; Yılmaz S
Int J Rheum Dis; 2024 Mar; 27(3):e15129. PubMed ID: 38514928
[TBL] [Abstract][Full Text] [Related]
17. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
[TBL] [Abstract][Full Text] [Related]
18. African League Against Rheumatism (AFLAR) preliminary recommendations on the management of rheumatic diseases during the COVID-19 pandemic.
Akintayo RO; Bahiri R; El Miedany Y; Olaosebikan H; Kalla AA; Adebajo AO; Migowa AN; Slimani S; Koussougbo OD; Kawther BA; Akpabio AA; Ghozlani I; Dey D; Hassan WA; Govind N; Makan K; Mohamed A; Genga EK; Ghassem MKA; Mortada M; Hamdi W; Wabi MO; Tikly M; Ngandeu-Singwe M; Scott C
Clin Rheumatol; 2021 Sep; 40(9):3445-3454. PubMed ID: 32876786
[TBL] [Abstract][Full Text] [Related]
19. Self-protection strategies and health behaviour in patients with inflammatory rheumatic diseases during the COVID-19 pandemic: results and predictors in more than 12 000 patients with inflammatory rheumatic diseases followed in the Danish DANBIO registry.
Glintborg B; Jensen DV; Engel S; Terslev L; Pfeiffer Jensen M; Hendricks O; Ostergaard M; Horskjær Rasmussen S; Adelsten T; Colic A; Danebod K; Kildemand M; Loft AG; Munk HL; Pedersen JK; Østgård RD; Møller Sørensen C; Krogh NS; Agerbo J; Ziegler C; Hetland M
RMD Open; 2021 Jan; 7(1):. PubMed ID: 33402443
[TBL] [Abstract][Full Text] [Related]
20. [A cross sectional study on patients with inflammatory rheumatic diseases in terms of their compliance to their immunsuppressive medication during COVID-19 pandemic].
Schmeiser T; Broll M; Dormann A; Fräbel C; Hermann W; Hudowenz O; Keil F; Müller-Ladner U; Özden F; Pfeiffer U; Saech J; Schwarting A; Stapfer G; Steinchen N; Storck-Müller K; Strunk J; Thiele A; Triantafyllias K; Wassenberg S; Wilden E; Hasseli R
Z Rheumatol; 2020 May; 79(4):379-384. PubMed ID: 32303821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
